Anastrozole IP

Anastrozole IP Specification

Molecular Weight
293.366 GSM (gm/2)

Structural Formula
C17H19N5

Molecular Formula
C17H19N5

Melting Point
81 C to 82 C

Heavy Metal (%)
<20 PPM

Medicine Name
Anastrozole IP

Chemical Name
Anastrozole

CAS No
120511-73-1

Type
Pharmaceutical Intermediates

Grade
Other

Usage
Anastrozole is commonly prescribed as adjuvant therapy, first-line treatment for advanced breast cancer, and as extended therapy following tamoxifen.

Purity(%)
100.32%

Appearance
White color, crystalline powder

Physical Form
Powder

Anastrozole IP Trade Information

Minimum Order Quantity
100 Grams

Delivery Time
1 Week

About Anastrozole IP

Anastrozole is a non-steroidal, selective aromatase inhibitor widely used in the treatment of hormone-receptor-positive breast cancer in postmenopausal women. It acts by inhibiting the aromatase enzyme responsible for converting androgens into estrogens, thereby significantly lowering circulating estrogen levels and reducing the stimulation of estrogen-dependent tumor growth. Anastrozole is commonly prescribed as adjuvant therapy, first-line treatment for advanced breast cancer, and as extended therapy following tamoxifen. Due to its efficacy, oral convenience, and favorable safety profile, anastrozole is a key agent in endocrine cancer therapy. Synonyms: Arimidex, Anastrozol, Anastrozolum, ZD-1033.